TrialNature communications2026
A phase II peri-operative study of pembrolizumab plus lenvatinib for mucosal melanoma.
Lili Mao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papertrialcites it
TrialNature communications2026
Lili Mao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.